Plasmacytoma - 153 Studies Found Completed : Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2008-01-31 : Drug: bortezomib Active, not recruiting : Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction : Multiple Myeloma Plasma Cell Neoplasm : 2008-11-13 : Drug: Group A=30-60 CrCl (mL/min) Active, not recruiting : Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma : Multiple Myeloma Plasma Cell Neoplasm : 2008-08-06 : Drug: lenalidomide combined wi Completed : Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant : Multiple Myeloma and Plasma Cell Neoplasm : 2008-01-15 : Biological: sargramostim Drug: melphalan Completed : Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2007-12-05 : Drug: bortezomib Drug: hydroxychloroquine Terminated : Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2007-12-01 : Biological: rituximab Drug: lenalidomide Completed : Activated White Blood Cells in Treating Patients Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Stage II or Stage III Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2007-11-30 : Biological: therapeutic autologous lymphocytes Completed : High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2007-09-05 : Biological: filgrastim Biological: pegfilg Completed : Bortezomib, Doxorubicin Hydrochloride Liposome, and Thalidomide as First-line Therapy in Treating Patients With Previously Untreated Stage I, II, or III Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2007-08-31 : Drug: bortezomib IV Withdrawn : Bortezomib, Arsenic Trioxide, and Melphalan in Treating Patients Undergoing an Autologous Stem Cell Transplant For Multiple Myeloma : Multiple Myeloma and Plasma Cell Neoplasm : 2007-07-17 : Drug: Arsenic trioxide Arsenic <<< Previous | Next >>>
